2025 APDD Summit
PLATFORM PRESENTATION APDD 2025 Summit:
Sabirnetug overview and use of a pTau217 Assay as a Marker of Amyloid Burden for Screening Participants in an Ongoing Phase 2 Study, ALTITUDE-AD
PLATFORM PRESENTATION APDD 2025 Summit:
Sabirnetug overview and use of a pTau217 Assay as a Marker of Amyloid Burden for Screening Participants in an Ongoing Phase 2 Study, ALTITUDE-AD